Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 76 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZHENG W, Xiang YT, Yang XH, Xiang YQ, et al
    Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2017 Mar 28. doi: 10.4088/JCP.16r10782.
    PubMed     Text format     Abstract available


  2. KASTER TS, Daskalakis ZJ, Blumberger DM
    Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10686.
    PubMed     Text format     Abstract available


  3. GERRETSEN P, Voineskos AN, Graff-Guerrero A, Menon M, et al
    Insight Into Illness and Cognition in Schizophrenia in Earlier and Later Life.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10741.
    PubMed     Text format     Abstract available


    January 2017
  4. JENSEN KG, Correll CU, Ruda D, Klauber DG, et al
    Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    J Clin Psychiatry. 2017 Jan 17. doi: 10.4088/JCP.15m10479.
    PubMed     Text format     Abstract available


  5. HAUSER M, Zhang JP, Sheridan EM, Burdick KE, et al
    Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    J Clin Psychiatry. 2017;78:e28-e40.
    PubMed     Text format     Abstract available


    December 2016
  6. HAMDANI N, Daban-Huard C, Godin O, Laouamri H, et al
    Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
    J Clin Psychiatry. 2016 Dec 6. doi: 10.4088/JCP.15m10133.
    PubMed     Text format     Abstract available


  7. ANDRADE C
    Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance.
    J Clin Psychiatry. 2016;77:e1656-e1660.
    PubMed     Text format     Abstract available


  8. GUINA J, Gupta A, Langleben DD, Elman I, et al
    Clinical Correlates of Oral Glucose Tolerance Test Performance in Olanzapine-Treated Patients with Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2016;77:e1650-e1651.
    PubMed     Text format    


  9. WEAMER EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, et al
    Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.
    J Clin Psychiatry. 2016;77:e1564-e1569.
    PubMed     Text format     Abstract available


  10. IWATA Y, Nakajima S, Caravaggio F, Suzuki T, et al
    Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2016;77:e1557-e1563.
    PubMed     Text format     Abstract available


    November 2016
  11. O'DONNELL CP, Allott KA, Murphy BP, Yuen HP, et al
    Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Nov 8. doi: 10.4088/JCP.15m10185.
    PubMed     Text format     Abstract available


  12. ZHANG C, Chen MJ, Wu GJ, Wang ZW, et al
    Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    J Clin Psychiatry. 2016;77:e1460-e1466.
    PubMed     Text format     Abstract available


    October 2016
  13. BRADFORD DW, Goulet J, Hunt M, Cunningham NC, et al
    A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer.
    J Clin Psychiatry. 2016 Oct 25. doi: 10.4088/JCP.15m10281.
    PubMed     Text format     Abstract available


  14. TANG C, Subramaniam M, Ng BT, Abdin E, et al
    Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective.
    J Clin Psychiatry. 2016 Oct 11. doi: 10.4088/JCP.15m10063.
    PubMed     Text format     Abstract available


  15. SAKURAI H, Suzuki T, Bies RR, Pollock BG, et al
    Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial.
    J Clin Psychiatry. 2016;77:1381-1390.
    PubMed     Text format     Abstract available


    September 2016
  16. BURGERHOUT KM, Kamperman AM, Roza SJ, Lambregtse-Van den Berg MP, et al
    Functional Recovery After Postpartum Psychosis: A Prospective Longitudinal Study.
    J Clin Psychiatry. 2016 Sep 13. doi: 10.4088/JCP.15m10204.
    PubMed     Text format     Abstract available


  17. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions.
    J Clin Psychiatry. 2016;77:e1090-e1094.
    PubMed     Text format     Abstract available


  18. CANGA E, Puerto M, Ortega L, Sole M, et al
    Parental Antecedents of Psychosis Are Associated With Severity of Positive and Negative Symptoms in Schizophrenia Patients.
    J Clin Psychiatry. 2016;77:1201-1202.
    PubMed     Text format    


  19. MISDRAHI D, Tessier A, Swendsen J, Berna F, et al
    Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
    J Clin Psychiatry. 2016;77:e1130-e1136.
    PubMed     Text format     Abstract available


    August 2016
  20. NASRALLAH HA, Newcomer JW, Risinger R, Du Y, et al
    Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.15m10467.
    PubMed     Text format     Abstract available


  21. YOUNG-XU Y, Duh MS, Muser E, DerSarkissian M, et al
    Impact of Paliperidone Palmitate versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.16m10745.
    PubMed     Text format     Abstract available


  22. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 2: Nonpharmacological Interventions.
    J Clin Psychiatry. 2016;77:e964-e967.
    PubMed     Text format     Abstract available


  23. NOTARAS M, Hill RA, Buuse MV
    Dissecting a Genomic Role of BDNF in Schizophrenia and Psychosis.
    J Clin Psychiatry. 2016;77:e1029-e1031.
    PubMed     Text format    


  24. ZHANG XY, Chen DC, Tan YL, Tan S, et al
    BDNF Polymorphisms Are Associated With Cognitive Performance in Schizophrenia Patients Versus Healthy Controls.
    J Clin Psychiatry. 2016;77:e1011-e1018.
    PubMed     Text format     Abstract available


    July 2016
  25. LOEBEL A, Silva R, Goldman R, Watabe K, et al
    Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Jul 19. doi: 10.4088/JCP.16m10698.
    PubMed     Text format     Abstract available


  26. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the Problem.
    J Clin Psychiatry. 2016;77:e844-7.
    PubMed     Text format     Abstract available


    June 2016
  27. CORRELL CU, Maayan L, Kane J, Hert M, et al
    Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2016;77:e746-e756.
    PubMed     Text format     Abstract available


  28. ANDRADE C
    Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    J Clin Psychiatry. 2016;77:e739-e742.
    PubMed     Text format     Abstract available


    May 2016
  29. TOHEN M, Khalsa HK, Salvatore P, Zarate CA Jr, et al
    The McLean-Harvard First-Episode Project: early course in 114 cases of first-episode nonaffective psychoses.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  30. ALAMEDA L, Golay P, Baumann PS, Ferrari C, et al
    Age at the time of exposure to trauma modulates the psychopathological profile in patients with early psychosis.
    J Clin Psychiatry. 2016;77:e612-8.
    PubMed     Text format     Abstract available


  31. SUN L, Qing Y, Yang X, Yang C, et al
    Gene expression profiling of the xMHC region reveals 9 candidate genes in schizophrenia.
    J Clin Psychiatry. 2016;77:e597-9.
    PubMed     Text format    


  32. WEIDEN PJ
    How many treatments before clozapine? medication choices across the spectrum of treatment resistance in schizophrenia.
    J Clin Psychiatry. 2016;77:e594-6.
    PubMed     Text format    


  33. WU CS, Wang SC, Yeh IJ, Liu SK, et al
    Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    J Clin Psychiatry. 2016;77:e573-9.
    PubMed     Text format     Abstract available


  34. FONTANELLA CA, Campo JV, Phillips GS, Hiance-Steelesmith DL, et al
    Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
    J Clin Psychiatry. 2016;77:661-7.
    PubMed     Text format     Abstract available


    April 2016
  35. CLOUTIER M, Sanon Aigbogun M, Guerin A, Nitulescu R, et al
    The economic burden of schizophrenia in the United States in 2013.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  36. LOZANO R, Franco ME, Marin R, Santacruz MJ, et al
    Anemia among schizophrenic patients: influence of clozapine and C-reactive protein.
    J Clin Psychiatry. 2016;77:e467.
    PubMed     Text format    


  37. WEHLER CA, Preskorn SH
    High false-positive rate of a putative biomarker test to aid in the diagnosis of schizophrenia.
    J Clin Psychiatry. 2016;77:e451-6.
    PubMed     Text format     Abstract available


    March 2016
  38. SCHOOLER NR, Marder SR, Chengappa KN, Petrides G, et al
    Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  39. ROCHON-TERRY G, Gruneir A, Seeman MV, Ray JG, et al
    Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  40. WIDSCHWENDTER CG, Rettenbacher MA, Kemmler G, Edlinger M, et al
    Bilirubin concentration correlates with positive symptoms in patients with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  41. KANTROWITZ JT, Sharif Z, Medalia A, Keefe RS, et al
    A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


    February 2016
  42. HUI L, Han M, Huang XF, Ye MJ, et al
    Association between DbetaH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  43. DRAKE RJ, Addington J, Viswanathan AC, Lewis SW, et al
    How age and gender predict illness course in a first-episode nonaffective psychosis cohort.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  44. MILLER BJ, Dias JK, Lemos HP, Buckley PF, et al
    An open-label, pilot trial of adjunctive tocilizumab in schizophrenia.
    J Clin Psychiatry. 2016;77:275-6.
    PubMed     Text format    


  45. VINOGRADOV S, Schulz SC
    Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:12-6.
    PubMed     Text format     Abstract available


  46. GREEN MF
    Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:8-11.
    PubMed     Text format     Abstract available


  47. SCHULZ SC, Murray A
    Assessing cognitive impairment in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:3-7.
    PubMed     Text format     Abstract available


  48. HIPPMAN C, Ringrose A, Inglis A, Cheek J, et al
    A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses.
    J Clin Psychiatry. 2016;77:e190-8.
    PubMed     Text format     Abstract available


    January 2016
  49. BORLIDO C, Remington G, Graff-Guerrero A, Arenovich T, et al
    Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry. 2016;77:e14-20.
    PubMed     Text format     Abstract available


  50. DIMITROV DH, Lee S, Yantis J, Honaker C, et al
    Elevated serum levels of high-sensitivity C-reactive proteins are associated with severe delusional symptoms in a subgroup of patients with schizophrenia.
    J Clin Psychiatry. 2016;77:131-2.
    PubMed     Text format    


  51. CITROME L, Durgam S, Lu K, Ferguson P, et al
    The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.
    J Clin Psychiatry. 2016;77:109-15.
    PubMed     Text format     Abstract available


  52. LEO RJ, DuBois RL
    A case of olfactory groove meningioma misdiagnosed as schizophrenia.
    J Clin Psychiatry. 2016;77:67-8.
    PubMed     Text format     Abstract available


  53. CORRELL CU, Citrome L, Haddad PM, Lauriello J, et al
    The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    J Clin Psychiatry. 2016;77.
    PubMed     Text format     Abstract available


    December 2015
  54. ZHANG XY, Fan FM, Chen DC, Tan YL, et al
    Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  55. MAYORAL-VAN SON J, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Moreno T, et al
    Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  56. DURGAM S, Cutler AJ, Lu K, Migliore R, et al
    Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
    J Clin Psychiatry. 2015;76:e1574-82.
    PubMed     Text format     Abstract available


    November 2015
  57. HUNG GC, Liu HC, Yang SY, Pan CH, et al
    Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  58. GERSTENBERG M, Hauser M, Al-Jadiri A, Sheridan EM, et al
    Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
    J Clin Psychiatry. 2015;76:e1449-58.
    PubMed     Text format     Abstract available


    October 2015
  59. PARELLADA M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, et al
    Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  60. LURIE I, Yang YX, Haynes K, Mamtani R, et al
    Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  61. PETRAKIS IL
    How to best treat patients with schizophrenia and co-occurring alcohol use disorder.
    J Clin Psychiatry. 2015;76:e1338-9.
    PubMed     Text format    


  62. BATKI SL
    What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?
    J Clin Psychiatry. 2015;76:e1336-7.
    PubMed     Text format    


  63. JANNEY CA, Ganguli R, Tang G, Cauley JA, et al
    Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders.
    J Clin Psychiatry. 2015;76:e1277-84.
    PubMed     Text format     Abstract available


  64. VAN SCHEPENDOM J, Yu W, Gielen J, Laton J, et al
    Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?
    J Clin Psychiatry. 2015;76:e1292-9.
    PubMed     Text format     Abstract available


    September 2015
  65. LIPEROTI R, Bernabei R, Onder G
    Managing antipsychotic medications in schizophrenia: comprehensive assessment and personalized care to improve clinical outcomes and reduce costs.
    J Clin Psychiatry. 2015;76:e1159-60.
    PubMed     Text format    


  66. LAURIELLO J, Rahman T
    Do long-term side effects matter? evaluating the risk of hip fracture in subjects with schizophrenia over a decade.
    J Clin Psychiatry. 2015;76:e1157-8.
    PubMed     Text format    


  67. LOPEZ LV, Kane JM
    Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.
    J Clin Psychiatry. 2015;76:1249-50.
    PubMed     Text format    


  68. DAVIS JM, Ramsden CE
    Do antipsychotics cause hip fractures? Promise and pitfalls of big data.
    J Clin Psychiatry. 2015;76:e1155-6.
    PubMed     Text format    


    August 2015
  69. GREEN AI, Brunette MF, Dawson R, Buckley P, et al
    Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  70. SULLIVAN G, Mittal D, Reaves CM, Haynes TF, et al
    Influence of schizophrenia diagnosis on providers' practice decisions.
    J Clin Psychiatry. 2015;76:1068-74.
    PubMed     Text format     Abstract available


  71. RANNING A, Munk Laursen T, Thorup A, Hjorthoj C, et al
    Serious mental illness and disrupted caregiving for children: a nationwide, register-based cohort study.
    J Clin Psychiatry. 2015;76:e1006-14.
    PubMed     Text format     Abstract available


    July 2015
  72. SHAH KA, Abraham MA, Espinosa JB
    A case of psychosis associated with Pai You Guo slimming capsules containing sibutramine.
    J Clin Psychiatry. 2015;76:e893-e894.
    PubMed     Text format    


  73. SUN X, Hamer R, McEvoy J
    Asenapine once daily versus twice daily: impact on patient acceptance in a randomized, open-label, 14-day clinical trial.
    J Clin Psychiatry. 2015;76:992-3.
    PubMed     Text format    


    June 2015
  74. WU CS, Chang CM, Tsai YT, Huang YW, et al
    Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  75. MELTZER HY, Risinger R, Nasrallah HA, Du Y, et al
    A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  76. KANE JM, Correll CU
    Making the link between science and symptoms in schizophrenia.
    J Clin Psychiatry. 2015;76:e15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: